Haleon plc (NYSE:HLN) Receives $10.95 Average PT from Analysts

Shares of Haleon plc (NYSE:HLNGet Free Report) have earned a consensus recommendation of “Buy” from the six analysts that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation, four have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $10.95.

A number of analysts have recently issued reports on the stock. Berenberg Bank started coverage on shares of Haleon in a research note on Tuesday, August 6th. They set a “buy” rating on the stock. UBS Group raised shares of Haleon to a “strong-buy” rating in a research note on Tuesday, October 1st. The Goldman Sachs Group cut shares of Haleon from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 6th. Finally, Morgan Stanley lifted their target price on Haleon from $9.90 to $10.95 and gave the stock an “overweight” rating in a research report on Friday, September 20th.

Read Our Latest Research Report on HLN

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. FMR LLC raised its stake in shares of Haleon by 5.8% in the 3rd quarter. FMR LLC now owns 104,918,269 shares of the company’s stock valued at $1,110,035,000 after purchasing an additional 5,768,117 shares in the last quarter. Sculptor Capital LP increased its holdings in Haleon by 67.8% in the second quarter. Sculptor Capital LP now owns 8,887,098 shares of the company’s stock valued at $73,407,000 after buying an additional 3,592,000 shares during the last quarter. Clearbridge Investments LLC raised its stake in Haleon by 8.6% during the second quarter. Clearbridge Investments LLC now owns 41,753,987 shares of the company’s stock valued at $344,888,000 after buying an additional 3,307,009 shares in the last quarter. Wellington Management Group LLP lifted its holdings in Haleon by 49.9% during the 3rd quarter. Wellington Management Group LLP now owns 9,152,490 shares of the company’s stock worth $96,833,000 after buying an additional 3,046,841 shares during the last quarter. Finally, The Manufacturers Life Insurance Company grew its position in shares of Haleon by 95.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,954,304 shares of the company’s stock worth $16,143,000 after acquiring an additional 954,622 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors.

Haleon Stock Performance

Shares of NYSE:HLN opened at $9.72 on Friday. The business’s 50-day simple moving average is $9.95 and its 200 day simple moving average is $9.41. The company has a market cap of $44.00 billion, a P/E ratio of 28.59, a PEG ratio of 2.89 and a beta of 0.30. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon has a one year low of $7.89 and a one year high of $10.80.

About Haleon

(Get Free Report

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Featured Stories

Analyst Recommendations for Haleon (NYSE:HLN)

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.